[go: up one dir, main page]

ZA200107283B - Vascular adhesion molecules and modulation of their function. - Google Patents

Vascular adhesion molecules and modulation of their function.

Info

Publication number
ZA200107283B
ZA200107283B ZA200107283A ZA200107283A ZA200107283B ZA 200107283 B ZA200107283 B ZA 200107283B ZA 200107283 A ZA200107283 A ZA 200107283A ZA 200107283 A ZA200107283 A ZA 200107283A ZA 200107283 B ZA200107283 B ZA 200107283B
Authority
ZA
South Africa
Prior art keywords
adhesion molecules
modulation
function
vascular adhesion
cram
Prior art date
Application number
ZA200107283A
Other languages
English (en)
Inventor
Beat Albert Imhof
Michel Aurrand-Lions
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of ZA200107283B publication Critical patent/ZA200107283B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
ZA200107283A 1999-03-11 2001-09-03 Vascular adhesion molecules and modulation of their function. ZA200107283B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200746 1999-03-11

Publications (1)

Publication Number Publication Date
ZA200107283B true ZA200107283B (en) 2002-12-24

Family

ID=8239973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107283A ZA200107283B (en) 1999-03-11 2001-09-03 Vascular adhesion molecules and modulation of their function.

Country Status (23)

Country Link
US (3) US7393651B2 (xx)
EP (2) EP2292761A1 (xx)
JP (2) JP4836329B2 (xx)
CN (2) CN100469878C (xx)
AT (1) ATE500328T1 (xx)
AU (1) AU782139B2 (xx)
BR (1) BR0008915A (xx)
CA (1) CA2362896C (xx)
CZ (1) CZ303128B6 (xx)
DE (1) DE60045681D1 (xx)
EE (1) EE05497B1 (xx)
ES (1) ES2361905T3 (xx)
HK (1) HK1044169A1 (xx)
HU (1) HU229376B1 (xx)
IL (1) IL145310A0 (xx)
IS (1) IS2819B (xx)
MX (1) MXPA01009110A (xx)
NO (1) NO333085B1 (xx)
NZ (1) NZ514091A (xx)
PL (1) PL207994B1 (xx)
RU (1) RU2244748C2 (xx)
WO (1) WO2000053749A2 (xx)
ZA (1) ZA200107283B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
BR0008915A (pt) * 1999-03-11 2002-04-09 Rmf Dictagene Sa Polipeptìdeo em forma isolada, anticorpos, polipeptìdeo solúvel, poli-ou oligonucleotideo, e processo para a identificação especìfica de sequências de adn diferentemente expressas
GB0100750D0 (en) * 2001-01-11 2001-02-21 Inpharmatica Ltd Novel proteins
WO2003006673A2 (en) * 2001-07-11 2003-01-23 Texas Biotechnology Corporation A nucleic acid encoding a human junctional adhesion protein (jam3)
EP1533617A1 (en) 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
US7642341B2 (en) 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
MX360959B (es) 2005-11-04 2018-11-23 Genentech Inc Uso de inhibidores de la vía del complemento para tratar enfermedades oculares.
RU2464030C2 (ru) * 2006-05-26 2012-10-20 Регадо Байосайенсиз, Инк. Введение противосвертывающей системы reg1
WO2008038127A2 (en) 2006-09-28 2008-04-03 Merck Serono S.A. Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use
RU2474589C9 (ru) 2006-11-02 2019-08-15 Дженентек, Инк. Гуманизированные антитела к фактору d и их применения
FR2909092B1 (fr) * 2006-11-24 2012-10-19 Pf Medicament Nouveaux anticorps anti-proliferation
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
SG183682A1 (en) * 2007-08-06 2012-09-27 Noxxon Pharma Ag Sdf-1 binding nucleic acids and the use thereof
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
CA2944712A1 (en) 2014-05-01 2015-11-05 Genentech, Inc. Anti-factor d antibody variants and uses thereof
TW201730211A (zh) 2015-10-30 2017-09-01 建南德克公司 抗因子d抗體及結合物
EP3368090A1 (en) 2015-10-30 2018-09-05 H. Hoffnabb-La Roche Ag Anti-factor d antibody variant conjugates and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053753A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US20030170864A1 (en) * 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
EP0973892A2 (en) * 1997-03-14 2000-01-26 Human Genome Sciences, Inc. 28 human secreted proteins
WO1998042739A2 (en) * 1997-03-21 1998-10-01 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2296809A1 (en) 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins identified from brain tissues
US20030049676A1 (en) 1997-09-17 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1002864A1 (en) 1998-11-10 2000-05-24 Universita' degli studi di Bologna HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
KR100468978B1 (ko) * 1998-12-16 2005-02-02 제넨테크, 인크. 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
BR0008915A (pt) * 1999-03-11 2002-04-09 Rmf Dictagene Sa Polipeptìdeo em forma isolada, anticorpos, polipeptìdeo solúvel, poli-ou oligonucleotideo, e processo para a identificação especìfica de sequências de adn diferentemente expressas
US7642341B2 (en) 2003-12-18 2010-01-05 Merck Serono S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer
EP1533617A1 (en) 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer

Also Published As

Publication number Publication date
NO20014417L (no) 2001-11-12
CZ20013267A3 (cs) 2002-02-13
EP1163337B1 (en) 2011-03-02
PL207994B1 (pl) 2011-02-28
AU782139B2 (en) 2005-07-07
ATE500328T1 (de) 2011-03-15
HUP0200606A2 (en) 2002-06-29
US7393651B2 (en) 2008-07-01
HUP0200606A3 (en) 2004-11-29
US7670826B2 (en) 2010-03-02
JP2010233572A (ja) 2010-10-21
WO2000053749A2 (en) 2000-09-14
NZ514091A (en) 2004-01-30
EP2292761A1 (en) 2011-03-09
US8143056B2 (en) 2012-03-27
EP1163337A2 (en) 2001-12-19
CA2362896A1 (en) 2000-09-14
EE05497B1 (et) 2011-12-15
HK1044169A1 (en) 2002-10-11
HU229376B1 (en) 2013-11-28
RU2244748C2 (ru) 2005-01-20
EE200100472A (et) 2002-12-16
NO20014417D0 (no) 2001-09-11
MXPA01009110A (es) 2002-08-20
JP2002537837A (ja) 2002-11-12
IL145310A0 (en) 2003-01-12
JP4836329B2 (ja) 2011-12-14
CA2362896C (en) 2012-07-31
US20100267649A1 (en) 2010-10-21
IS2819B (is) 2012-12-15
CN1355843A (zh) 2002-06-26
US20050266426A1 (en) 2005-12-01
AU4105100A (en) 2000-09-28
CN1637019A (zh) 2005-07-13
DE60045681D1 (de) 2011-04-14
WO2000053749A3 (en) 2000-12-14
NO333085B1 (no) 2013-02-25
US20080274970A1 (en) 2008-11-06
CZ303128B6 (cs) 2012-04-18
IS6072A (is) 2001-09-10
BR0008915A (pt) 2002-04-09
PL350417A1 (en) 2002-12-16
ES2361905T3 (es) 2011-06-24
CN100469878C (zh) 2009-03-18

Similar Documents

Publication Publication Date Title
HK1044169A1 (en) Vascular adhesion molecules and modulation of their function
PT1132403E (pt) Peptidos inibidores de tgf g beta1
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DK0770089T3 (da) Vækstdifferentieringsfaktor-12
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
BR9007115A (pt) Novo trombolitico
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
AU9743698A (en) Allelic variant of human stat3
BG105682A (en) Bone stimulating factor
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
EP0832109A4 (en) FACTOR-2, HOMOLOGY OF THE FIBROBLASTS GROWTH FACTOR AND METHOD FOR ITS APPLICATION
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
WO1999046381A3 (en) Human fgf gene and gene expression products